Melanoma is classified as an immunologically “hot” tumor, characterized by high levels of tumor-infiltrating lymphocytes (TILs), elevated expression of immune checkpoint molecules (e.g., PD-1, CTLA-4), and a high tumor mutational burden (TMB) [212]. The gene discussed is CTLA4; the disease is melanoma.